Literature DB >> 14634089

Role of antiproliferative B cell translocation gene-1 as an apoptotic sensitizer in activation-induced cell death of brain microglia.

Heasuk Lee1, Sanghoon Cha, Myung-Shik Lee, Gyeong Jae Cho, Wan Sung Choi, Kyoungho Suk.   

Abstract

Mouse brain microglial cells undergo apoptosis on exposure to inflammatory stimuli, which is considered as an autoregulatory mechanism to control their own activation. Here, we present evidence that an antiproliferative B cell translocation gene 1 (BTG1) constitutes a novel apoptotic pathway of LPS/IFN-gamma-activated microglia. The expression of BTG1 was synergistically enhanced by LPS and IFN-gamma in BV-2 mouse microglial cells as well as in primary microglia cultures. Levels of BTG1 expression inversely correlated with a proliferative capacity of the microglial cells. Tetracycline-based conditional expression of BTG1 not only suppressed microglial proliferation but also increased the sensitivity of microglial cells to NO-induced apoptosis, suggesting a novel mechanism of cooperation between LPS and IFN-gamma in the induction of microglial apoptosis. An increase in BTG1 expression, however, did not affect microglial production of NO, TNF-alpha, or IL-1beta, indicating that the antiproliferative BTG1 is important in the activation-induced apoptosis of microglia, but not in the activation itself. The synergistic action of LPS and IFN-gamma in the microglial BTG1 induction and apoptosis was dependent on the Janus kinase/STAT1 pathway, but not IFN-regulatory factor-1, as demonstrated by a pharmacological inhibitor of Janus kinase (AG490), STAT1 dominant negative mutant, and IFN-regulatory factor-1-deficient mice. Taken together, antiproliferative BTG1 may participate in the activation-induced cell death of microglia by lowering the threshold for apoptosis; BTG1 increases the sensitivity of microglia to apoptogenic action of autocrine cytotoxic mediator, NO. Our results point out an important link between the proliferative state of microglia and their sensitivity to apoptogenic agents.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14634089     DOI: 10.4049/jimmunol.171.11.5802

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  21 in total

1.  Identification of BTG1 Status in Solid Cancer for Future Researches Using a System Review and Meta-analysis.

Authors:  Xiu-Qiong Chen; Fan-Qiao Meng; Hua Xiong; Ya-Li Wang; Wen-Hua Tang; Yan-Mei Zou
Journal:  Curr Med Sci       Date:  2020-03-13

2.  EZH2 Represses the B Cell Transcriptional Program and Regulates Antibody-Secreting Cell Metabolism and Antibody Production.

Authors:  Muyao Guo; Madeline J Price; Dillon G Patterson; Benjamin G Barwick; Robert R Haines; Anna K Kania; John E Bradley; Troy D Randall; Jeremy M Boss; Christopher D Scharer
Journal:  J Immunol       Date:  2017-12-29       Impact factor: 5.422

3.  The expression of BTG1 is downregulated in nasopharyngeal carcinoma and possibly associated with tumour metastasis.

Authors:  G G Sun; Y D Wang; Y J Cheng; W N Hu
Journal:  Mol Biol Rep       Date:  2014-07-02       Impact factor: 2.316

4.  Molecular cloning, sequence analysis, and cadmium stress-rated expression changes of BTG1 in freshwater pearl mussel (Hyriopsis schlegelii).

Authors:  Kou Peng; Cheng-Yuan Wang; Jun-Hua Wang; Jun-Qing Sheng; Jian-Wu Shi; Jian Li; Yi-Jiang Hong
Journal:  Dongwuxue Yanjiu       Date:  2014-09

5.  Circulating microRNAs involved in multiple sclerosis.

Authors:  Sue Rutherford Siegel; Jason Mackenzie; George Chaplin; Nina G Jablonski; Lyn Griffiths
Journal:  Mol Biol Rep       Date:  2012-01-10       Impact factor: 2.316

6.  TRAIL pathway is associated with inhibition of colon cancer by protopanaxadiol.

Authors:  Zhiyu Zhang; Zejuan Li; Xiaohui Wu; Chun-Feng Zhang; Tyler Calway; Tong-Chuan He; Wei Du; Jianjun Chen; Chong-Zhi Wang; Chun-Su Yuan
Journal:  J Pharmacol Sci       Date:  2014-11-18       Impact factor: 3.337

7.  Diversity of clinical implication of B-cell translocation gene 1 expression by histopathologic and anatomic subtypes of gastric cancer.

Authors:  Mitsuro Kanda; Hisaharu Oya; Shuji Nomoto; Hideki Takami; Dai Shimizu; Ryoji Hashimoto; Satoshi Sueoka; Daisuke Kobayashi; Chie Tanaka; Suguru Yamada; Tsutomu Fujii; Goro Nakayama; Hiroyuki Sugimoto; Masahiko Koike; Michitaka Fujiwara; Yasuhiro Kodera
Journal:  Dig Dis Sci       Date:  2014-12-09       Impact factor: 3.199

8.  BTG1 underexpression is an independent prognostic marker in esophageal squamous cell carcinoma.

Authors:  G G Sun; Y D Wang; Y J Cheng; W N Hu
Journal:  Tumour Biol       Date:  2014-06-27

Review 9.  Global genomic characterization of acute lymphoblastic leukemia.

Authors:  Charles G Mullighan; James R Downing
Journal:  Semin Hematol       Date:  2009-01       Impact factor: 3.851

10.  The expression of BTG1 is downregulated in NSCLC and possibly associated with tumor metastasis.

Authors:  G G Sun; Y F Lu; Y J Cheng; W N Hu
Journal:  Tumour Biol       Date:  2013-11-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.